BioRem Inc. (TSXV:BRM)
Canada flag Canada · Delayed Price · Currency is CAD
3.490
+0.320 (10.09%)
May 21, 2026, 3:59 PM EST

BioRem Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
44.4442.3637.4225.1728.8624.48
Revenue Growth (YoY)
22.66%13.19%48.69%-12.81%17.91%0.42%
Cost of Revenue
31.3929.5927.3618.1420.118.24
Gross Profit
13.0512.7710.067.028.766.24
Selling, General & Admin
6.326.145.623.915.793.91
Research & Development
0.040.050.040.030.10.01
Other Operating Expenses
-0.140.080.050.020.240.24
Total Operating Expenses
6.236.285.713.966.124.17
Operating Income
6.76.494.343.062.642.07
Interest Expense
-0.15-0.16-0.2-0.27-0.26-0.04
Total Non-Operating Income (Expense)
-0.15-0.16-0.2-0.27-0.26-0.04
Pretax Income
6.556.334.152.792.382.03
Provision for Income Taxes
1.571.511.10.610.770.74
Net Income
4.984.823.042.181.611.3
Net Income to Common
4.984.823.042.181.611.3
Net Income Growth
81.79%58.25%39.66%35.11%24.34%-37.89%
Shares Outstanding (Basic)
161616161536
Shares Outstanding (Diluted)
191919171837
Shares Change (YoY)
-0.97%-0.40%9.40%-2.55%-53.08%-5.32%
EPS (Basic)
0.310.300.190.140.100.04
EPS (Diluted)
0.270.260.160.130.090.03
EPS Growth
84.64%62.50%23.08%41.48%164.97%-30.64%
Shares Outstanding
16.1316.1316.1415.715.515.48
Free Cash Flow
1.277.273.31-0.061.243.71
Free Cash Flow Growth
-82.59%119.45%---66.50%23.48%
Free Cash Flow Per Share
0.080.390.18-0.000.070.10
Gross Margin
29.36%30.14%26.87%27.90%30.36%25.48%
Operating Margin
15.08%15.32%11.61%12.17%9.15%8.46%
Profit Margin
11.21%11.37%8.13%8.66%5.59%5.30%
FCF Margin
2.85%17.17%8.85%-0.25%4.30%15.14%
EBITDA
7.136.964.823.452.992.41
EBITDA Margin
16.05%16.44%12.87%13.69%10.36%9.86%
EBIT
6.76.494.343.062.642.07
EBIT Margin
15.08%15.32%11.61%12.17%9.15%8.46%
Effective Tax Rate
23.96%23.89%26.63%21.86%32.32%36.23%
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.